Sunday November 8 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Dysplastic Nevus Syndrome

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Dysplastic Nevus Syndrome:

Pubmed Logo
The reticular point of view in dermatoscopy.
BACKGROUND: Different dermatoscopic algorithms have been developed to...
9th October, 2009
Department of Dermatology and Plastic Surgery, University of Rome J Am Acad Dermatol. 2009 Oct;61(4):605-10. Epub 2009 Aug 22.
DOI Direct Link
Early diagnosis of melanotic melanoma based on laser-induced melanin fluorescence.
Because of the increasing incidence of skin cancer, interest in using the...
23rd September, 2009
Praxis fur Dermatologie, Kurfurstendamm 139, Berlin 10711, Germany. J Biomed Opt. 2009 May-Jun;14(3):034033.
DOI Direct Link
WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.
OBJECTIVE: Recent studies indicate that WT1 and Bcl2 protein are detected...
21st August, 2009
Department of Neuropathology and Ophthalmic Pathology, Armed Forces Arch Ophthalmol. 2009 Aug;127(8):964-9.
DOI Direct Link
Nucleolin protein expression in cutaneous melanocytic lesions.
BACKGROUND: Nucleolin is a major nucleolar argyrophilic protein involved...
20th August, 2009
Department of Human Pathology and Oncology, Section of Pathological J Cutan Pathol. 2009 Jun;36(6):637-46.
DOI Direct Link
Neurofibromatosis type 1 associated with dysplastic nevus syndrome.
Neurofibromatosis type 1 (NF-1) is an autosomal dominant disorder that...
15th July, 2009
University Department of Dermatology and Venereology, Zagreb University Acta Dermatovenerol Croat. 2009;17(2):118-22.

View more research publications.

Press Releases About Dysplastic Nevus Syndrome:

BioPortfolio Logo
Research Findings Key for Understanding, Interpreting Genetic Testing for Long QT Syndrome 5th November, 2009 Mayo Clinic
Study has Important Implications for Genetic Testing and Individualized Medicine ROCHESTER, Minn., Nov. 5 /PRNewswire-USNewswire/ -- Results of a long QT syndrome (LQTS) study published in the current
Regado Biosciences to Present at the 3rd Annual Canaccord Adams Cardiovascular Conference on November 10, 2009 3rd November, 2009 Regado Biosciences
BASKING RIDGE, N.J., Nov. 3 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that David J.
Regeneron Reports Third Quarter 2009 Financial and Operating Results 3rd November, 2009 Regeneron Pharmaceuticals, Inc.
TARRYTOWN, N.Y., Nov. 3 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced financial and operating results for the third quarter of 2009. The Company reported a
/C O R R E C T I O N -- American Epilepsy Outreach Foundation/ 2nd November, 2009 American Epilepsy Outreach Foundation
In the news release, Helmets for Hope Campaign and Gala, issued 02-Nov-2009 by American Epilepsy Outreach Foundation over PR Newswire, we are advised by the organization that the first paragraph,
NCCN Updates Colorectal Screening Guidelines to Include Additional Primary Screening Modality 2nd November, 2009 National Comprehensive Cancer Network
Although colonoscopy remains the preferred colorectal cancer screening method, the recently updated NCCN Guidelines for Colorectal Cancer Screening have added annual immunohistochemical stool testing

Dysplastic Nevus Syndrome Clinical Trials:

Clinical Trials Logo
Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome

Dysplastic Nevus Syndrome Patents:

USPTO Logo
US Patent No.Title
6124303 Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones
6232312 Method for treating patient having precancerous lesions with a combination of pyrimidopyrimidine derivatives and esters and amides of substituted indenyl acetic acides
6239136 Method of treating a patient having precancerous lesions with phenyl pyrimidinone derivatives
6262059 Method of treating a patient having precancerous lesions with quinazoline derivatives
6268372 Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Dysplastic Nevus Syndrome scientists - we have details of around 89 individuals working on Dysplastic Nevus Syndrome .


This page has been viewed 585 times
Recent Search Terms used to find this page: dysplastic nevus | dysplastic mole | dysplastic nevus syndrome | dysplastic nevus syndrome clinical trials | Dysplastic nevus syndrome | dysplastic nevus | dysplastic nevus | dysplastic mole imaging 2009 | Dysplastic nevus syndrome | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Dysplastic Nevus Syndrome across BioPortfolio, or for Dysplastic Nevus Syndrome Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.